why was tirzepatide banned WADA just added (mounjaro) to the 2026 Monitoring Program Demand for Unapproved Weight-Loss Drug

Additives per kg: According to the manufacturer, this product contains no additives

Using anything else is an unnecessary risk

Compounding pharmacies are stepping up as a cost-effective alternative to brand-name drugs, offering personalized formulations to meet individual needs

These data reflect exposure of 718 patients to MOUNJARO and a mean duration of exposure to MOUNJARO of 36.6 weeks

Safety and efficacy of VYVANSE were evaluated in a double-blind, randomized, parallel-group, placebo-controlled, fixed-dose study in pediatric patients ages 4 to 5 years with ADHD, followed by a 1-year open-label extension study